Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylp henyl)methanol

Details for Australian Patent Application No. 2010213580 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.

Agent Davies Collison Cave

Pub. Number AU-A-2010213580

PCT Pub. Number WO2010/093930

Priority 61/152,494 13.02.09 US

Filing date 12 February 2010

Wipo publication date 19 August 2010

International Classifications

A61K 31/4174 (2006.01)

A61P 23/00 (2006.01) Anaesthetics

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/093930 Priority application(s): WO2010/093930

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010213583-Communicating with data storage systems

2010213578-Mutant ROS expression in human cancer